Interchange Capital Partners LLC Takes Position in Tempus AI, Inc. (NASDAQ:TEM)

Interchange Capital Partners LLC bought a new position in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund bought 6,567 shares of the company's stock, valued at approximately $214,000.

Other large investors have also added to or reduced their stakes in the company. ARK Investment Management LLC boosted its holdings in shares of Tempus AI by 132.1% during the fourth quarter. ARK Investment Management LLC now owns 5,519,644 shares of the company's stock worth $186,343,000 after acquiring an additional 3,141,487 shares during the period. Sumitomo Mitsui Trust Group Inc. boosted its stake in Tempus AI by 166.0% in the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,239,093 shares of the company's stock valued at $109,352,000 after purchasing an additional 2,021,394 shares during the period. Nikko Asset Management Americas Inc. boosted its stake in Tempus AI by 166.0% in the 4th quarter. Nikko Asset Management Americas Inc. now owns 3,239,093 shares of the company's stock valued at $109,352,000 after purchasing an additional 2,021,394 shares during the period. NEA Management Company LLC grew its holdings in Tempus AI by 17.8% in the 3rd quarter. NEA Management Company LLC now owns 5,385,979 shares of the company's stock valued at $304,846,000 after buying an additional 813,169 shares in the last quarter. Finally, Teacher Retirement System of Texas bought a new position in Tempus AI during the 4th quarter worth $13,504,000. Institutional investors own 24.22% of the company's stock.

Analyst Upgrades and Downgrades

TEM has been the topic of several research reports. JPMorgan Chase & Co. downgraded shares of Tempus AI from an "overweight" rating to a "neutral" rating and upped their price target for the company from $50.00 to $55.00 in a research note on Tuesday, February 25th. Needham & Company LLC increased their target price on shares of Tempus AI from $56.00 to $70.00 and gave the stock a "buy" rating in a research report on Tuesday, February 25th. Piper Sandler dropped their price target on shares of Tempus AI from $70.00 to $55.00 and set a "neutral" rating for the company in a research report on Tuesday, March 4th. Bank of America increased their price target on Tempus AI from $54.00 to $60.00 and gave the stock a "neutral" rating in a research report on Monday, March 3rd. Finally, TD Cowen restated a "buy" rating and set a $74.00 price objective (up previously from $58.00) on shares of Tempus AI in a research note on Wednesday, February 5th. Six research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $61.18.

Remove Ads

Tempus AI Price Performance

Shares of TEM stock traded down $5.17 on Wednesday, hitting $53.40. 8,142,202 shares of the company's stock were exchanged, compared to its average volume of 13,698,214. The company has a 50 day moving average of $57.42 and a 200 day moving average of $51.46. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. Tempus AI, Inc. has a 12 month low of $22.89 and a 12 month high of $91.45.

Insiders Place Their Bets

In related news, COO Ryan Fukushima sold 20,000 shares of the firm's stock in a transaction on Tuesday, January 7th. The stock was sold at an average price of $39.61, for a total transaction of $792,200.00. Following the sale, the chief operating officer now owns 982,442 shares of the company's stock, valued at $38,914,527.62. This trade represents a 2.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, major shareholder Bradley A. Keywell sold 265,000 shares of the company's stock in a transaction dated Friday, January 17th. The stock was sold at an average price of $35.10, for a total value of $9,301,500.00. Following the completion of the transaction, the insider now directly owns 15,218,365 shares of the company's stock, valued at approximately $534,164,611.50. The trade was a 1.71 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 5,598,969 shares of company stock valued at $317,194,162.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.